Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

2,010 companies reported in the last 14 days · showing 2001–2010 · updated Thu, Nov 19, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
ATYRaTyr Pharma, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$18.0M n/m −$7.43 n/m — — $10M
SINTSiNtx Technologies, Inc. Healthcare Nov 5 Sep '26 $2.0M n/m −$2.0M n/m −$0.24 n/m -74.7% — $9M
PHIOPhio Pharmaceuticals Corp. Healthcare Nov 5 Sep '26 $0.0M n/m −$4.0M n/m −$0.36 n/m — — $9M
INABIN8bio, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$5.0M n/m −$0.24 n/m — — $8M
CDLXCardlytics, Inc. Communication Services Nov 5 Sep '26 $33.0M −36.5% −$9.0M n/m −$1.52 n/m -16.5% +115.8 pp $7M
INTSIntensity Therapeutics, Inc. Healthcare Nov 5 Sep '26pending — — — — — — — — $7M
ACHAccendra Health, Inc. Healthcare Nov 5 Sep '26 $602M −13.6% −$20.0M n/m $0.00 n/m 0.2% −7.9 pp $7M
VEEETwin Vee PowerCats Co. Consumer Cyclical Nov 5 Sep '26pending $2.8M† −7.6% — — — — — — $4M
CGTLCreative Global Technology Holdings Limited Consumer Cyclical Nov 5 Sep '26pending $2.4M† n/m — — — — — — $3M
REVBRevelation Biosciences, Inc. Healthcare Nov 5 Sep '26pending — — — — — — — — $2M
  • Report dates come from the earnings calendar (dates loaded Oct 5 to Dec 10); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.